We have heard that some pharmacies are having trouble getting stock of Tegretol (carbamazepine) Prolonged Release tablets.
There is a shortage of Wockhardt sodium valproate 200mg/5ml oral solution.
There is a temporary shortage of the following oxcarbazepine tablets:
- Trileptal 150mg
- Sandoz oxcarbazepine 150mg
Novartis, who make both of these medicines, have told us they expect them to be back in stock from mid-April 2022.
Other strengths of Trileptal and Sandoz oxcarbazepine are in stock. Other manufacturers’ versions of oxcarbazepine are also available.
If you have any concerns about getting your usual medicine, please speak to your pharmacist or GP for advice.
Update: 9 March 2022
Supply of this medicine is now back to normal.
Epilim Chrono stock
We have received a further statement from Sanofi about this supply issue:
Accord have discontinued their 25mg lamotrigine tablets.
The Medicines and Healthcare products Regulatory Agency (MHRA) is recalling three batches of Epilim 500mg Gastro-Resistant tablets from pharmacies.
Mylan have discontinued their version of carbamazepine, called Carbagen.
Carbagen has been out of stock since January 2019, so most people will have already switched to a different manufacturer’s version of carbamazepine. If you are still taking Carbagen we recommend speaking to your GP or epilepsy specialist as soon as possible, as it is unlikely there will be much stock left.
Dr Reddy's Laboratories (UK) Ltd have stopped making their version of zonisamide capsules. This applies to all strengths.